Literature DB >> 27162092

Impaired postprandial lipemic response in chronic kidney disease.

Jeffrey M Saland1, Lisa M Satlin2, Jeanna Zalsos-Johnson2, Serge Cremers3, Henry N Ginsberg3.   

Abstract

Dyslipidemia in chronic kidney disease (CKD) is usually characterized by hypertriglyceridemia. Here we studied postprandial lipemia in children and young adults to determine whether an increasing degree of CKD results in a proportional increase in triglyceride and chylomicron concentration. Secondary goals were to determine whether subnephrotic proteinuria, apolipoprotein (apo)C-III and insulin resistance modify the CKD effect. Eighteen fasting participants (mean age of 15 years, mean glomerular filtration rate (GFR) of 50 ml/min/1.73 m(2)) underwent a postprandial challenge with a high fat milkshake. Triglycerides, apoB-48, insulin, and other markers were measured before and 2, 4, 6, and 8 hours afterward. Response was assessed by the incremental area under the curve of triglycerides and of apoB-48. The primary hypothesis was tested by correlation to estimated GFR. Significantly, for every 10 ml/min/1.73 m(2) lower estimated GFR, the incremental area under the curve of triglycerides was 17% greater while that of apoB-48 was 16% greater. Univariate analyses also showed that the incremental area under the curve of triglycerides and apoB-48 were significantly associated with subnephrotic proteinuria, apoC-III, and insulin resistance. In multivariate analysis, CKD and insulin resistance were independently associated with increased area under the curve and were each linked to increased levels of apoC-III. Thus, postprandial triglyceride and chylomicron plasma excursions are increased in direct proportion to the degree of CKD. Independent effects are associated with subclinical insulin resistance and increased apoC-III is linked to both CKD and insulin resistance.
Copyright © 2016 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  chronic kidney disease; insulin resistance; lipids; nutrition; pediatric nephrology

Mesh:

Substances:

Year:  2016        PMID: 27162092      PMCID: PMC4912421          DOI: 10.1016/j.kint.2016.02.031

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  47 in total

1.  Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man.

Authors:  J D Brunzell; W R Hazzard; D Porte; E L Bierman
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

2.  Dyslipidemia in children with chronic kidney disease.

Authors:  Jeffrey M Saland; Christopher B Pierce; Mark M Mitsnefes; Joseph T Flynn; Jens Goebel; Juan C Kupferman; Bradley A Warady; Susan L Furth
Journal:  Kidney Int       Date:  2010-08-25       Impact factor: 10.612

3.  Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice.

Authors:  Y Ito; N Azrolan; A O'Connell; A Walsh; J L Breslow
Journal:  Science       Date:  1990-08-17       Impact factor: 47.728

Review 4.  Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences.

Authors:  N D Vaziri
Journal:  Am J Physiol Renal Physiol       Date:  2006-02

5.  Down-regulation of hepatic LDL receptor-related protein (LRP) in chronic renal failure.

Authors:  Choong Kim; Nosratola D Vaziri
Journal:  Kidney Int       Date:  2005-03       Impact factor: 10.612

6.  Quantitative determination of human apolipoprotein C-III by electroimmunoassay.

Authors:  M D Curry; W J McConathy; J D Fesmire; P Alaupovic
Journal:  Biochim Biophys Acta       Date:  1980-03-21

7.  Severe defect in clearing postprandial chylomicron remnants in dialysis patients.

Authors:  M Weintraub; A Burstein; T Rassin; M Liron; Y Ringel; S Cabili; M Blum; G Peer; A Iaina
Journal:  Kidney Int       Date:  1992-11       Impact factor: 10.612

8.  Loss-of-function mutations in APOC3, triglycerides, and coronary disease.

Authors:  Jacy Crosby; Gina M Peloso; Paul L Auer; David R Crosslin; Nathan O Stitziel; Leslie A Lange; Yingchang Lu; Zheng-zheng Tang; He Zhang; George Hindy; Nicholas Masca; Kathleen Stirrups; Stavroula Kanoni; Ron Do; Goo Jun; Youna Hu; Hyun Min Kang; Chenyi Xue; Anuj Goel; Martin Farrall; Stefano Duga; Pier Angelica Merlini; Rosanna Asselta; Domenico Girelli; Oliviero Olivieri; Nicola Martinelli; Wu Yin; Dermot Reilly; Elizabeth Speliotes; Caroline S Fox; Kristian Hveem; Oddgeir L Holmen; Majid Nikpay; Deborah N Farlow; Themistocles L Assimes; Nora Franceschini; Jennifer Robinson; Kari E North; Lisa W Martin; Mark DePristo; Namrata Gupta; Stefan A Escher; Jan-Håkan Jansson; Natalie Van Zuydam; Colin N A Palmer; Nicholas Wareham; Werner Koch; Thomas Meitinger; Annette Peters; Wolfgang Lieb; Raimund Erbel; Inke R Konig; Jochen Kruppa; Franziska Degenhardt; Omri Gottesman; Erwin P Bottinger; Christopher J O'Donnell; Bruce M Psaty; Christie M Ballantyne; Goncalo Abecasis; Jose M Ordovas; Olle Melander; Hugh Watkins; Marju Orho-Melander; Diego Ardissino; Ruth J F Loos; Ruth McPherson; Cristen J Willer; Jeanette Erdmann; Alistair S Hall; Nilesh J Samani; Panos Deloukas; Heribert Schunkert; James G Wilson; Charles Kooperberg; Stephen S Rich; Russell P Tracy; Dan-Yu Lin; David Altshuler; Stacey Gabriel; Deborah A Nickerson; Gail P Jarvik; L Adrienne Cupples; Alex P Reiner; Eric Boerwinkle; Sekar Kathiresan
Journal:  N Engl J Med       Date:  2014-06-18       Impact factor: 91.245

9.  Lipoprotein lipase-enhanced binding of human triglyceride-rich lipoproteins to heparan sulfate: modulation by apolipoprotein E and apolipoprotein C.

Authors:  H H van Barlingen; H de Jong; D W Erkelens; T W de Bruin
Journal:  J Lipid Res       Date:  1996-04       Impact factor: 5.922

10.  Transcriptional regulation of the apoC-III gene by insulin in diabetic mice: correlation with changes in plasma triglyceride levels.

Authors:  M Chen; J L Breslow; W Li; T Leff
Journal:  J Lipid Res       Date:  1994-11       Impact factor: 5.922

View more
  2 in total

1.  Change in Dyslipidemia with Declining Glomerular Filtration Rate and Increasing Proteinuria in Children with CKD.

Authors:  Jeffrey M Saland; Juan C Kupferman; Christopher B Pierce; Joseph T Flynn; Mark M Mitsnefes; Bradley A Warady; Susan L Furth
Journal:  Clin J Am Soc Nephrol       Date:  2019-11-11       Impact factor: 8.237

Review 2.  A Comprehensive Update on the Chylomicronemia Syndrome.

Authors:  Ronald B Goldberg; Alan Chait
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-23       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.